ALEXANDRIA, VA / ACCESSWIRE / January 28, 2020 / SOLEI

New Post Public Reply Private Reply Replies (0) Message Board
wayno2
163
ALEXANDRIA, VA / ACCESSWIRE / January 28, 2020 / SOLEI SYSTEMS (OTC PINK:SOLI) a public holding company in the health and wellness field, is pleased to announce its application to the OTCQB Venture Market.

Today the company has initiated a strategy to upgrade its position in the public markets and increase its visibility to a wider range of investors through the process of uplisting to the OTCQB. The company has submitted the OTCQB application materials to OTC Markets Group.

President Josh Flood commented, "Uplisting to OTCQB is a natural milestone in Solei's growth journey. We are thrilled to further enhance our capabilities to deliver meaningful support services so individuals have better access to quality healthcare. Telemedicine is gaining momentum - and CareClix, Inc., our wholly owned subsidiary, is gaining traction and momentum in this sector."

The company already meets OTCQB Venture Market compliance requirements by filing audited annual financials prepared in accordance with U.S. GAAP which have been audited by a PCAOB auditor and maintains a Verified Company Profile at OTCMarkets.com.

For more information on Solei Systems, please visit the company's corporate website at http://www.soleihealth.com Investors wishing to subscribe to the company's Investor Alert system are asked to fill in the appropriate fields at the bottom of the Investor Relations page to receive notices of S.E.C. filings, press releases after they cross the newswire, periodic newsletters, and other information about Solei Systems' business that management believes will be of interest to holders of the company's stock.

About Solei

Solei Systems Inc is a fully reporting, fully audited public holding company in the health and wellness field with its primary focus on telemedicine. Currently, Solei Systems, Inc is comprised of two wholly owned subsidiaries: CareClix, Inc. and Clinical & Herbal Innovations, Inc.

Contact

Solei Systems, Inc
206 N. Washington St. Suite 100
Alexandria, VA 22314
T: (703) 832-4473
www.soleihealth.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Protecting Shareholder Rights: iRhythm Technologies Update

Updated Category News Views 104

Understanding Your Rights as a Shareholder For shareholders of iRhythm Technologies, Inc. (NASDAQ: IRTC), it's imperative to be proactive regarding your rights. Engaging with legal experts can significantly empower your ability to affect change and seek justice for any personal or collective grievances stemming from corporate actions. Why Shareholder Action is Crucial...

Continue Reading
Discover the New Credit Risk IQ and its Industry Insights

Updated Category News Views 138

Introducing Credit Risk IQ Credit Benchmark, a leader in delivering essential credit risk data and analytics, has launched an exciting new platform called Credit Risk IQ. This online portal features an extensive library of over 5,000 free monthly reports that explore credit trends at both industry and sector levels. The insights found in these reports are invaluable for...

Continue Reading
9Rooftops Retained as Marketing Agency for South Carolina Tourism

Updated Category News Views 233

9Rooftops Reappointed for South Carolina Tourism Marketing 9Rooftops, known for its innovative marketing strategies, has been reappointed as the Marketing and Advertising Agency of Record for the South Carolina Department of Parks, Recreation & Tourism (SCPRT). This marks a continued partnership aimed at showcasing the beauty and attractions of South Carolina. A...

Continue Reading
Kyivstar Enhances Digital Services with AI Cloud Solutions

Updated Category News Views 203

Kyivstar Revolutionizes Cloud Services with AI Integration Kyivstar Group Ltd (Nasdaq: KYIV; KYIVW) has embarked on an ambitious journey to strengthen digital services within Ukraine. The company has officially announced the integration of groundbreaking artificial intelligence (AI) technologies into its cloud platform, Kyivstar Cloud. This advancement is pivotal for all...

Continue Reading
Akeso Advances Cancer Care with Ivonescimab Phase III Trial Launch

Updated Category News Views 171

Akeso Launches Phase III Trial for Ivonescimab in SCLC Akeso, Inc. (9926.HK) recently announced an exciting milestone in cancer treatment with the first patient being dosed in its Phase III clinical trial. This multicenter, randomized, and double-blind study, named AK112-311/HARMONi-9, evaluates the efficacy and safety of ivonescimab, a unique bispecific antibody that...

Continue Reading